Twist Bioscience dips after starting $250 mln stock offering
BUZZ-Twist Bioscience dips after starting $250 mln stock offering ** Biotech firm Twist Bioscience's TWST.O shares dip 1.1% to $98.38 post-market after equity raise news
** TWST commences $250 mln stock offering
** Co intends to use net offering proceeds for R&D, expansion of manufacturing capacity, product offerings, remainder for other purposes
** Goldman Sachs, William Blair, Leerink and Guggenheim joint bookrunners
** South San Francisco, California-based firm has ~62.7 mln shares outstanding for about $6.2 bln market cap
** Stock finished down 1.6% at $99.44, but has more than tripled YTD
** Avg rating of 10 analysts is "buy"; median PT $112, per LSEG data
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))